Ironwood Pharmaceuticals, Inc.IRWDNASDAQ
LOADING
|||
Price to Sales: Discounted Valuation
Trending lower, below historical average, structural decline.
Left:
||||
Price-to-sales ratio
Latest
2.01
↓ 64% below average
Average (9y)
5.59
Historical baseline
Range
High:11.02
Low:2.01
CAGR
-17.2%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 2.01 | -50.1% |
| 2023 | 4.02 | -13.8% |
| 2022 | 4.66 | +1.9% |
| 2021 | 4.57 | -1.9% |
| 2020 | 4.66 | -3.8% |
| 2019 | 4.85 | +6.3% |
| 2018 | 4.56 | -38.8% |
| 2017 | 7.46 | -7.8% |
| 2016 | 8.09 | -26.6% |
| 2015 | 11.02 | - |